Join Precision experts Ross Maclean, Dominic Galante and Maureen Hennessey as they offer insights into trends that are gaining velocity. Watch "Beyond the First 100 Days: Healthcare Policy and Value-Based Care Trends That You Need to Know" on-demand today.
Inequities in social determinants of health (SDOH) increase the risk of death from COVID-19 for racial and ethnic minority groups. Precision's Maureen Hennessey identifies steps pharma, health plans, and integrated delivery networks (IDNs) can take to address SDOH to safely establish community immunity.
Cancer care has been disproportionately impacted by the COVID-19 pandemic, possibly leading to later-stage cancers and increasing patient morbidity and mortality, as well as regression in the strides made in cancer care and overall patient survival. The oncology ecosystem is determined to do all it can to not only prevent these regressions but also to accelerate further advancements. Precision's Elizabeth Oyekan outlines 10 observed trends and developments to further optimize cancer care in 2021 and beyond.
The rise of innovative new therapeutic interventions means that payers need more information than ever to properly assess treatments, as well as compare them with existing methods of care. They also can benefit from collaborations with manufacturers, including on innovative pricing models. Precision's Reta Mourad joins other experts for a discussion of the opportunities and challenges facing payers as they confront antiquated reimbursement models and work to develop new payment models that include therapeutic value assessments.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
